StockData
Radiopharm Theranostics Ltd logo

Radiopharm Theranostics Ltd (RADX) stock

RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 30, 2026Score 6/30
$0.76−0.03 (-3.80%)

Close on Nov 13, 2026Market cap $8.98MP/E –Yield –

Radiopharm Theranostics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Radiopharm Theranostics's price to sales ratio was 3.0× on Nov 11, 2026, against 8.7× a year earlier. Over the last 2 years it ranged from 3.0× to 23.6×, with a median of 10.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.0×−6.9
2025Dec 31, 202510.0×−9.4
2024Dec 31, 202419.3×–

More Radiopharm Theranostics figures

See a number that looks wrong?